Company information
- Ticker
- MGRX
- Country
- United States
- Sector
- Health Care
- Industry
- Health Care Technology
MANGOCEUTICALS Business Summary
Mangoceuticals, Inc. (MGRX) operates a vertically integrated telemedicine platform that generates revenue through a direct-to-consumer (DTC) model, utilizing subscription-based recurring billing and per-transaction fees for prescription and over-the-counter wellness products. The company’s business is organized into four core segments: sexual health (ED treatments under the "MangoRx" and "PeachesRx" brands), hair loss ("Grow"), medical weight management (compounded GLP-1 agonists under "Slim"), and a functional oral pouch division established via the 2025 acquisition of Smokeless Technology Corp. Mangoceuticals differentiates itself through the use of compounded pharmaceutical formulations and innovative delivery systems, such as stimulant-infused pouches, to bypass traditional retail barriers. Key competitors include Hims & Hers Health, Inc. (HIMS), Ro (Roman), and BlueChew. Relative to these peers, Mangoceuticals positions itself as an agile, micro-cap challenger focusing on specialized compounded solutions and rapid international scaling, particularly within the Mexican and Latin American markets. The leadership team is anchored by Co-Founder, CEO, and Chairman Jacob Cohen, an entrepreneur with a 20-year background in capital markets and investment banking who manages the company’s corporate strategy and financing. He is supported by President Antonios Isaac, who oversees operational growth initiatives, and Chief Operating Officer Amanda Hammer, a digital operations expert formerly of D Magazine Partners. In 2025, the company significantly bolstered its executive pedigree by appointing Tim Corkum—a former executive at Philip Morris International and JUUL Labs—to lead its high-growth Pouch Division. Financial oversight is provided by CFO Eugene M. Johnston, while the board includes independent directors such as Lorraine D'Alessio and Dr. Kenny Myers. This team is currently focused on transitioning the company from its early-stage infrastructure toward a multi-format wellness platform, leveraging strategic IP acquisitions and influencer-driven marketing to drive platform adoption.